Enterprise Value
-29.99M
Cash
61.1M
Avg Qtr Burn
-5.931M
Short % of Float
0.81%
Insider Ownership
2.27%
Institutional Own.
10.38%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
HONEDRA (CLBS12) Details Critical limb ischemia | Phase 3 Update | |
LSTA1 Details Pancreatic cancer, Cancer | Phase 2b Update | |
LSTA201 (CLBS201) Details Chronic kidney disease | Failed Discontinued | |
XOWNA (CLBS16) Details Coronary Microvascular Dysfunction | Failed Discontinued | |
OLOGO (CLBS14) Details Angina | Failed Discontinued |